Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Provisional guidelines for measuring disease activity in clinical trials on rheumatoid arthritis.

× No keyword cloud information.

16 in total

1. Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis.

Authors: T Uhlig; T K Kvien; J L Jensen; T Axéll
Journal: Ann Rheum Dis Date: 1999-07 Impact factor: 19.103

Review 2. Clinical outcome measures in rheumatoid arthritis.

Authors: P L van Riel; A M van Gestel
Journal: Ann Rheum Dis Date: 2000-11 Impact factor: 19.103

Review 3. Are American College of Rheumatology 50% response criteria superior to 20% criteria in distinguishing active aggressive treatment in rheumatoid arthritis clinical trials reported since 1997? A meta-analysis of discriminant capacities.

Authors: C P Chung; J L Thompson; G G Koch; I Amara; V Strand; T Pincus
Journal: Ann Rheum Dis Date: 2006-02-27 Impact factor: 19.103

Review 4. Tenidap: not just another NSAID?

Authors: J M Canvin; R Madhok
Journal: Ann Rheum Dis Date: 1996-02 Impact factor: 19.103

Review 5. Criteria for TNF-targeted therapy in rheumatoid arthritis: estimates of the number of patients potentially eligible.

Authors: T K Kvien; T Uhlig; I S Kristiansen
Journal: Drugs Date: 2001 Impact factor: 9.546

6. Declines in number of tender and swollen joints in patients with rheumatoid arthritis seen in standard care in 1985 versus 2001: possible considerations for revision of inclusion criteria for clinical trials.

Authors: T Pincus; T Sokka; C P Chung; G Cawkwell
Journal: Ann Rheum Dis Date: 2005-12-08 Impact factor: 19.103

Review 7. The underestimated long term medical and economic consequences of rheumatoid arthritis.

Authors: T Pincus
Journal: Drugs Date: 1995 Impact factor: 9.546

Review 8. Should contemporary rheumatoid arthritis clinical trials be more like standard patient care and vice versa?

Authors: T Pincus; T Sokka
Journal: Ann Rheum Dis Date: 2004-11 Impact factor: 19.103

Review 9. Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis.

Authors: C P Rains; S Noble; D Faulds
Journal: Drugs Date: 1995-07 Impact factor: 9.546

10. Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene.

Authors: Y Berkun; D Levartovsky; A Rubinow; H Orbach; S Aamar; T Grenader; I Abou Atta; D Mevorach; G Friedman; A Ben-Yehuda
Journal: Ann Rheum Dis Date: 2004-10 Impact factor: 19.103